IRIS
DE SANCTIS, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.642
AS - Asia 2.672
EU - Europa 1.028
SA - Sud America 907
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 137
OC - Oceania 9
Totale 9.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.477
SG - Singapore 1.498
BR - Brasile 759
CN - Cina 473
VN - Vietnam 374
IT - Italia 342
FI - Finlandia 139
IE - Irlanda 118
CA - Canada 93
DE - Germania 85
FR - Francia 69
NG - Nigeria 69
GB - Regno Unito 65
HK - Hong Kong 63
AR - Argentina 62
IN - India 51
TR - Turchia 43
NL - Olanda 35
SE - Svezia 34
MX - Messico 32
BD - Bangladesh 29
RU - Federazione Russa 28
EC - Ecuador 26
IQ - Iraq 24
ES - Italia 21
ZA - Sudafrica 21
ID - Indonesia 18
IL - Israele 16
MA - Marocco 16
BE - Belgio 15
CO - Colombia 15
CL - Cile 14
JP - Giappone 12
UA - Ucraina 12
EU - Europa 10
PY - Paraguay 10
EG - Egitto 9
PL - Polonia 9
VE - Venezuela 9
CR - Costa Rica 8
SA - Arabia Saudita 8
AU - Australia 7
CZ - Repubblica Ceca 7
NI - Nicaragua 7
PK - Pakistan 7
RO - Romania 7
IR - Iran 6
NP - Nepal 6
KE - Kenya 5
PE - Perù 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DZ - Algeria 4
EE - Estonia 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
HR - Croazia 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
SN - Senegal 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
AT - Austria 3
BO - Bolivia 3
BW - Botswana 3
ET - Etiopia 3
KZ - Kazakistan 3
MD - Moldavia 3
NO - Norvegia 3
OM - Oman 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
KR - Corea 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BM - Bermuda 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
IM - Isola di Man 1
JE - Jersey 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
Totale 9.403
Salva come PNG Salva come JPEG
Città #
Singapore 628
Wilmington 469
Ashburn 316
San Jose 243
Chandler 232
The Dalles 222
Dallas 186
Shanghai 174
San Mateo 172
Ann Arbor 166
Helsinki 139
Council Bluffs 136
New York 126
Beijing 122
Ho Chi Minh City 119
Dublin 118
Milan 109
Leawood 101
Hanoi 95
Princeton 92
Boardman 91
Lawrence 85
São Paulo 71
Benin City 67
Hong Kong 60
Santa Clara 60
Fairfield 56
Los Angeles 53
Paris 53
Toronto 45
Woodbridge 45
Phoenix 44
Rio de Janeiro 39
Rome 39
Kocaeli 31
Amsterdam 27
London 26
Seattle 22
Brooklyn 21
Atlanta 17
Chicago 17
Assago 16
Montreal 16
San Diego 16
Brussels 15
Buffalo 15
Orem 15
Cincinnati 14
Naples 14
Curitiba 13
Da Nang 13
Hải Dương 13
Brasília 12
Guayaquil 12
Haiphong 12
Miami 12
Monmouth Junction 12
Chennai 11
Figino 11
Kansas City 11
Mexico City 11
Tokyo 11
Buenos Aires 10
Fortaleza 10
Houston 10
Johannesburg 10
Munich 10
Recife 10
Biên Hòa 9
Las Vegas 9
Porto Alegre 9
The Bronx 9
Baghdad 8
Bradenton 8
Newark 8
Richmond 8
Abbeville 7
Denver 7
Falkenstein 7
Hillsboro 7
Managua 7
Natal 7
Norwalk 7
Oakland 7
Pune 7
Quito 7
San Francisco 7
Belo Horizonte 6
Brno 6
Casablanca 6
Charlotte 6
Dhaka 6
Erbil 6
Louisville 6
Manaus 6
New Delhi 6
Osasco 6
Salvador 6
Santiago 6
Warsaw 6
Totale 5.492
Salva come PNG Salva come JPEG
Nome #
Biological characteristics and long-term outcomes in node-negative breast cancer 130
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 127
Treatment of malignant pleural mesothelioma: current status and future directions 126
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab 121
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 120
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 118
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib 117
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 116
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 114
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 113
Safety and efficacy of oral combination of vinorelbine and capecitabine in metastatic breast cancer 112
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 112
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). 109
Imatinib mesylate in desmoplastic small round cell tumour 107
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB 105
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 102
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity 100
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study 100
Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience 98
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 98
A pilot analysis of headache disorders in breast cancer patients 97
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 96
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 96
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 96
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab 96
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava 95
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 91
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 90
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 90
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy 90
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 90
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 89
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma 89
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 88
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 88
First-line chemotherapy in over-70 patients with colon cancer. 87
Capecitabine in elderly patients with metastatic breast cancer 87
Clinical Review on the Management of Breast Cancer Visceral Crisis 85
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 85
A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients 85
Capecitabine in elderly breast cancer patients 85
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 85
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report 84
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 82
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 82
A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue 82
Dietary chemoprevention of colorectal cancer 81
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group 81
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial 80
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 79
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome 79
Opportunities and Challenges of Synthetic Data Generation in Oncology 78
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 78
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 78
Efficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma 78
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 78
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 77
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 77
Descripcion de un sistema de realidad virtual dirigido a la promocion de bienestar emocional en pazientes oncologicoa hospidalizados: ensayo fase II OncoHelp 77
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 77
Temporal–occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura 77
Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities 75
SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE 75
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 75
Never too old to fight breast cancer 74
The therapeutic potential of duloxetine in prostate cancer-related fatigue 74
Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach 73
HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome 73
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 72
Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report 71
Trabectedin for the treatment of soft tissue sarcoma 71
Trabectedin for the treatment of soft tissues sarcomas 69
Imatinib mesylate in desmoplastic small round cell tumors 69
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis 69
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy? 68
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 68
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 68
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 68
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 67
Sporadic desmoid tumors of the abdominal wall: the results of surgery 67
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice 67
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 67
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 66
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 66
Never too old to fight breast cancer: A case report 65
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 65
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 65
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen 64
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 63
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 63
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 63
Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine 62
[Integrated treatment of breast cancer: review of our experience] 61
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer 61
Profiling the Spectrum of Headache Disorders on 440 Breast Cancer Patients: Highlights on Clinical and Pathological Mechanisms 60
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 60
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 60
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 59
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 59
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib 58
Totale 8.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022396 0 0 0 79 14 7 12 64 44 77 89 10
2022/2023898 182 19 114 58 79 46 4 72 137 97 78 12
2023/2024779 54 63 164 34 30 110 52 32 8 21 67 144
2024/20251.215 27 3 4 11 15 173 51 118 216 276 151 170
2025/20263.821 486 621 236 419 154 150 825 170 216 212 105 227
2026/20271.367 345 253 580 189 0 0 0 0 0 0 0 0
Totale 9.556